The Food and Drug Administration (FDA) awarded a $754,024.73 firm-fixed-price contract to S-3 Research LLC, a minority-owned, self-certified small disadvantaged business, to acquire data and services to better understand consumers and potential health risks from cannabis-derived products (CDPs). The contract, which does not have a set-aside designation, has a completion date of February 12, 2027. S-3 Research is a data science company that provides research-as-a-service solutions to federal...
S-3 Research LLC was awarded a definitive firm fixed price contract valued at one hundred four thousand five hundred dollars by the Department of Health and Human Services Food and Drug Administration. The contract calls for the awardee to utilize big data, machine learning, and infoveillance approaches to detect and characterize adoption and adherence to pre-exposure prophylaxis therapy among minority populations. To be performed in Silver Spring, Maryland, the contract aims to provide insights...
The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
This is a $7,712,724.33 definitive, firm fixed-price contract awarded by the U.S. Food and Drug Administration (FDA) to Legitscript LLC, a small business, for internet monitoring services of FDA-regulated products. The contract has a period of performance through September 5, 2024. The original contract opportunity was a combined synopsis/solicitation for commercial services, designated as a 100% Total Small Business Set-Aside with a NAICS code of 541519. The contract provides for the...
The National Institute on Drug Abuse (NIDA) awarded a $279,863.98 Firm Fixed Price Definitive Contract to S-3 Research LLC, a minority-owned small disadvantaged business, to further develop a proof-of-concept machine learning approach to detect illegal opioid sellers and create a minimum viable product (MVP). This contract is set aside for small businesses. S-3 Research is a data science company that specializes in using big data, machine learning, and data visualization to address public health...
The U.S. Food and Drug Administration (FDA) awarded a $108,661 firm fixed-price purchase order contract to Sayari Analytics, LLC, a small disadvantaged business located in Washington, D.C. The contract provides the FDA with access to Sayari's Graph internet database tool, which enables advanced data analytics capabilities such as risk assessment, sanctions monitoring, financial transaction analysis, and network mapping. This award is associated with a larger $45 million single-award Small...
The U.S. Food and Drug Administration (FDA) awarded a $200,000 delivery order contract to Realm Research LLC, a minority-owned small disadvantaged woman-owned small business, to monitor the conduct and progress of extramural FDA-funded research studies in human subjects overseen by the Center for Drug Evaluation and Research (CDER). This contract is part of a larger $1.1 million indefinite delivery contract awarded to Realm Research in 2023 to provide broader scientific and clinical support...
This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $1,024,971 contract is for data resources and surveillance reports to support post-marketing monitoring of non-medical use of pharmaceuticals and illicit drug use. The contract has a six-month performance period with a completion date of September 29, 2026. This delivery order is part of a larger $10 million FDA indefinite...
The U.S. Food and Drug Administration (FDA) awarded a $2,320,370.49 Delivery Order contract to Sagacity Ventures LLC, an SBA-certified 8(a) joint venture that is a minority and women-owned small business. The contract is for subject matter expertise support related to the FDA's Bioresearch Monitoring (BIMO) Program and COVID-19 response efforts. The contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle set aside...
The U.S. Food and Drug Administration (FDA) awarded a $21,267,389.16 firm fixed price delivery order contract to Source Healthcare Analytics LLC, a global provider of outsourced development services. The contract aims to provide the FDA with access to outpatient prescription and patient-level drug utilization data over a five-year period to support the agency's drug safety monitoring efforts. This delivery order was issued under a $45 million single-award Indefinite Delivery Contract between the...